All News Advent Pharma Ltd.

Equities

ADVENT

BD0492ADVPL9

End-of-day quote Dhaka S.E. Other stock markets 06:00:00 2024-07-15 pm EDT			5-day change	1st Jan Change
27.8 ^BDT	-2.46%		-0.36%	+11.65%

Apr. 29	Advent Pharma Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	CI
Feb. 06	Advent Pharma Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	CI

All News

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Advent Pharma Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	Apr. 28	CI
Advent Pharma Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	Feb. 05	CI
Advent Pharma Ltd. Reports Earnings Results for the First Quarter Ended September 30, 2023	Nov. 13	CI
Advent Pharma Ltd. Recommends Cash Dividend for the Year Ended June 30, 2023	23-10-29	CI
Advent Pharma Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023	23-05-15	CI
Advent Pharma Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022	23-02-12	CI
Advent Pharma Ltd. Reports Earnings Results for the First Quarter Ended September 30, 2022	22-11-23	CI
Advent Pharma Ltd. Completes Signing Agreement of Distributorship with Alltech Biotechnology Pvt Ltd	22-11-17	CI
Advent Pharma Ltd. Recommends Cash Dividend for the Year Ended June 30, 2022	22-10-30	CI
Advent Pharma Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2022	22-05-24	CI
Advent Pharma Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2021	22-01-29	CI
Advent Pharma Ltd. Reports Earnings Results for the First Quarter Ended September 30, 2021	21-12-01	CI
Advent Pharma Ltd. Recommends Cash Dividend for the Year Ended on June 30, 2021	21-10-31	CI
Advent Pharma Ltd. Appoints Asif Iqbal Chowdhury as Chairman	21-05-06	CI
21,567,500 Ordinary Shares of Advent Pharma Limited are subject to a Lock-Up Agreement Ending on 12-APR-2021.	21-04-11	CI
Advent Pharma Ltd. Appoints Faria Binte Alam as the Managing Director	20-07-02	CI
Advent Pharma Ltd. Announces Approval to Introduce New Products	20-03-24	CI
Advent Pharma Ltd. Announces Approval to Introduce New Products	20-02-04	CI
Advent Pharma Ltd. Reports Earnings Results for the Second Quarter Ended December 31, 2019	20-01-29	CI
Advent Pharma Limited Reports Earnings Results for the First Quarter Ended September 30, 2019	19-10-29	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Advent Pharma Ltd.

Equities

ADVENT

BD0492ADVPL9

All News

Filters